In a breakthrough for longevity science, a reverse-aging treatment has been injected into a human. The technique is a sought-after solution for improving longevity by reprogramming cells. Competitors ...

Blindness itself might become, at least in certain cases, partially reversible. This potential future stems from one of the ...

A groundbreaking human trial of ER-100, a cellular reprogramming therapy, has begun, testing whether damaged eye cells can be ...

The first participant has been treated in a landmark clinical trial of cellular reprogramming, which aims to rejuvenate aging ...

Pleased to announce the first patient has been dosed in our Phase 1 clinical trial, evaluating our lead candidate for optic ...

Aging, at its most fundamental level, is a molecular process. Chemical marks on the genome shift and lose fidelity over time, ...

Life Biosciences says it just dosed its first patient in an FDA-approved clinical trial to reverse age-related blindness.

Cancer cells are quick to develop resistance to anti-tumor drugs. New research by scientists from the University of ...

Promising mouse studies and billions of dollars in funding are stoking excitement. But we’ve been here before.

Biotech startup NewLimit secures a major funding round after claiming a ‘breakthrough discovery’ of a prototype medicine that rewinds cellular aging in the liver.